Innovation

CYP2D6 and CYP3A4 double transgenic mice

University at Buffalo - The State University of New York
posted on 10/20/2009

Human CYP2D6 and CYP3A4 collectively metabolize over 70% of drugs on the market. In an effort to study the developmental and sexual expression and regulation of these two major human drug-metabolizing P450s, a double transgenic mouse line carrying both CYP2D6 and CYP3A4 transgenes (Tg-CYP2D6/CYP3A4) was generated by a pharmaceutical scientist at the University at Buffalo in collaboration with researchers at the National Cancer Institute. The CYP2D6/CYP3A4 double transgenic mouse model could provide insight into potential differences in CYP expression and induction and effects on drug-drug interactions (DDIs) between men and women. This mouse model could serve as a useful tool for preclinical drug development The mice and/or tissue samples are available for purchase and licensing. Additional information can be found in DMD 36:435-441, 2008.


Innovation Details
 

Detailed Description

Human CYP2D6 and CYP3A4 collectively metabolize over 70% of drugs on the market. In an effort to study the developmental and sexual expression and regulation of these two major human drug-metabolizing P450s, a double transgenic mouse line carrying both CYP2D6 and CYP3A4 transgenes (Tg-CYP2D6/CYP3A4) was generated by a pharmaceutical scientist at the University at Buffalo in collaboration with researchers at the National Cancer Institute. The CYP2D6/CYP3A4 double transgenic mouse model could provide insight into potential differences in CYP expression and induction and effects on drug-drug interactions (DDIs) between men and women. This mouse model could serve as a useful tool for preclinical drug developmentThe mice and/or tissue samples are available for purchase and licensing.Additional information can be found in DMD 36:435-441, 2008.

File Number: 6323 

Other Information: Principal Investigator: Aiming Yu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Tim Dee at University at Buffalo - The State University of New York for more information.

Request more info via email request more info
People

Case Manager:

Tim Dee Tim Dee

Innovations (40)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...